Company / Depreciation & Amortization
Nuo Therapeutics, Inc. Depreciation & Amortization History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.1M
FY2017
5-year range
$613.5K / $1.1M
FY2013-FY2017
Trend
+33.2%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $613,500 in FY2014 to $1M in FY2017.
Based on SEC 10-K filings.
$1M in FY2017 with a 5-year CAGR of -1.1%.
Increased from $740,973 to $1M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +22.0%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Nuo Therapeutics, Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of -1.1%, indicating a declining trend.
- In FY2017, depreciation & amortization increased 33.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2012.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $1.1M | +33.2% |
| FY2016 | $836.2K | +12.9% |
| FY2015 | $741.0K | +20.8% |
| FY2014 | $613.5K | -43.8% |
| FY2013 | $1.1M | -7.4% |
| FY2012 | $1.2M | +86.8% |
| FY2011 | $631.2K | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026